{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:32:50Z","timestamp":1791419570010,"version":"4.3.3"},"reference-count":202,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T00:00:00Z","timestamp":1454544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Polymorphisms in certain inflammatory-related genes have been identified as putative differential risk factors of neurodegenerative diseases with abnormal protein aggregates, such as sporadic Alzheimer\u2019s disease (AD) and sporadic Parkinson\u2019s disease (sPD). Gene expression studies of cytokines and mediators of the immune response have been made in post-mortem human brain samples in AD, sPD, sporadic Creutzfeldt-Jakob disease (sCJD) subtypes MM1 and VV2, Pick\u2019s disease (PiD), progressive supranuclear palsy (PSP) and frontotemporal lobar degeneration linked to mutation P301L in MAPT Frontotemporal lobar degeneration-tau (FTLD-tau). The studies have disclosed variable gene regulation which is: (1) disease-dependent in the frontal cortex area 8 in AD, sPD, sCJD MM1 and VV2, PiD, PSP and FTLD-tau; (2) region-dependent as seen when comparing the entorhinal cortex, orbitofrontal cortex, and frontal cortex area 8 (FC) in AD; the substantia nigra, putamen, FC, and angular gyrus in PD, as well as the FC and cerebellum in sCJD; (3) genotype-dependent as seen considering sCJD MM1 and VV2; and (4) stage-dependent as seen in AD at different stages of disease progression. These observations show that regulation of inflammation is much more complicated and diverse than currently understood, and that new therapeutic approaches must be designed in order to selectively act on specific targets in particular diseases and at different time points of disease progression.<\/jats:p>","DOI":"10.3390\/ijms17020206","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T10:26:22Z","timestamp":1454581582000},"page":"206","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies"],"prefix":"10.3390","volume":"17","author":[{"given":"Irene","family":"L\u00f3pez Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Institute of Neuropathology, Bellvitge University Hospital, IDIBELL, Barcelona 08034, Spain"},{"name":"CIBERNED (Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas), Institute Carlos III, Madrid 28029, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Garcia-Esparcia","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, Bellvitge University Hospital, IDIBELL, Barcelona 08034, Spain"},{"name":"CIBERNED (Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas), Institute Carlos III, Madrid 28029, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franc","family":"Llorens","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, Bellvitge University Hospital, IDIBELL, Barcelona 08034, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9888-8754","authenticated-orcid":false,"given":"Isidre","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Institute of Neuropathology, Bellvitge University Hospital, IDIBELL, Barcelona 08034, Spain"},{"name":"CIBERNED (Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas), Institute Carlos III, Madrid 28029, Spain"},{"name":"Department of Pathology and Experimental Therapeutics, University of Barcelona, 08907 Hospitalet de Llobregat, Barcelona 08034, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"key":"ref_1","unstructured":"Love, S., Budka, H., Ironside, J.W., and Perry, A. (2015). Greenfield\u2019s Neuropathology, CRC Press, Taylor & Francis Group. [9th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/glia.440010502","article-title":"Functional plasticity of microglia: A review","volume":"1","author":"Streit","year":"1988","journal-title":"Glia"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: A sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.brainresrev.2004.12.013","article-title":"Microglia and neuroprotection: Implications for Alzheimer\u2019s disease","volume":"48","author":"Streit","year":"2005","journal-title":"Brain Res. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1126\/science.1190929","article-title":"Chanching face of microglia","volume":"330","author":"Graeber","year":"2010","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","article-title":"Microglia: Biology and pathology","volume":"119","author":"Graeber","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2011.00077","article-title":"History of innate immunity in neurodegenerative disorders","volume":"2","author":"McGeer","year":"2011","journal-title":"Front. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1016\/j.febslet.2011.08.033","article-title":"Role of microglia in CNS inflammation","volume":"585","author":"Graeber","year":"2011","journal-title":"FEBS Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.50.4.986","article-title":"Non-steroidal anti-inflammatory drug use and Alzheimer-type pathology in aging","volume":"50","author":"Mackenzie","year":"1998","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/rheumatology\/28.1.86-b","article-title":"Rheumatoid arthritis and senile dementia of the Alzheimer\u2019s type","volume":"28","author":"Jenkinson","year":"1989","journal-title":"Br. J. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0140-6736(90)91101-F","article-title":"Anti-inflammatory drugs and Alzheimer disease","volume":"335","author":"McGeer","year":"1990","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/rheumatology\/33.5.501","article-title":"Alzheimer\u2019s disease and rheumatoid arthritis","volume":"33","author":"Isomaki","year":"1994","journal-title":"Rheumatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/0197-4580(95)00049-K","article-title":"Delayed onset of Alzheimer\u2019s disease with non-steroidal anti-inflammatory and histamine H2 blocking drugs","volume":"16","author":"Breitner","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.48.3.626","article-title":"Risk of Alzheimer\u2019s disease and duration of NSAID use","volume":"48","author":"Stewart","year":"1997","journal-title":"Neurology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3233\/JAD-2008-13402","article-title":"Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders","volume":"13","author":"Schwab","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.59.6.880","article-title":"Cache County Study Investigator. Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study","volume":"59","author":"Zandi","year":"2002","journal-title":"Neurology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/11316780-000000000-00000","article-title":"NSAID use and the risk of Parkinson\u2019s disease: Systematic review and meta-analysis of observational studies","volume":"26","author":"Samii","year":"2009","journal-title":"Drugs Aging"},{"key":"ref_22","first-page":"664","article-title":"Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4","volume":"59","author":"Rao","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(99)00867-8","article-title":"Association between apolipoprotein E polymorphism and Alzheimer\u2019s disease in Koreans","volume":"277","author":"Kim","year":"1999","journal-title":"Neurosci. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","article-title":"Systematic meta-analyses of Alzheimer disease genetic association studies, the AlzGene database","volume":"39","author":"Bertram","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4088\/JCP.v68n0419","article-title":"A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer\u2019s disease","volume":"68","author":"Coon","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","article-title":"Genetics of Alzheimer\u2019s disease","volume":"87","author":"Chouraki","year":"2014","journal-title":"Adv. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-2094-3-10","article-title":"Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice","volume":"3","author":"Maezawa","year":"2006","journal-title":"J. Neuroinflamm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1096\/fj.05-5423fje","article-title":"Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK","volume":"20","author":"Maezawa","year":"2006","journal-title":"FASEB J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.neuron.2008.04.010","article-title":"ApoE promotes the proteolytic degradation of Abeta","volume":"58","author":"Jiang","year":"2008","journal-title":"Neuron"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1523\/JNEUROSCI.5302-08.2009","article-title":"Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism","volume":"29","author":"Zhao","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7049","DOI":"10.1523\/JNEUROSCI.6546-10.2011","article-title":"Critical role of astroglial apolipoprotein E and liver X receptor-\u03b1 expression for microglial A\u03b2 phagocytosis","volume":"31","author":"Terwel","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/JMN:23:3:205","article-title":"A dual role for apolipoprotein E in neuroinflammation: Anti- and pro-inflammatory activity","volume":"23","author":"Guo","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.neurobiolaging.2006.07.007","article-title":"Genetic risk profiles for Alzheimer\u2019s disease: Integration of APOE genotype and variants that up-regulate inflammation","volume":"28","author":"Licastro","year":"2007","journal-title":"Neurobiol Aging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12264-013-1422-z","article-title":"Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer\u2019s disease","volume":"30","author":"Dorey","year":"2014","journal-title":"Neurosci. Bull."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/jnc.13072","article-title":"APOE-modulated A\u03b2-induced neuroinflammation in Alzheimer\u2019s disease, current landscape, novel data, and future perspective","volume":"133","author":"Tai","year":"2015","journal-title":"J. Neurochem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nbd.2007.09.001","article-title":"SORL1 variants and risk of late-onset Alzheimer\u2019s disease","volume":"29","author":"Li","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/archneurol.2010.201","article-title":"Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes","volume":"67","author":"Jun","year":"2010","journal-title":"Arch. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archneurol.2010.346","article-title":"Meta-analysis of the association between variants in SORL1 and Alzheimer disease","volume":"68","author":"Reitz","year":"2011","journal-title":"Arch. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/mp.2011.24","article-title":"Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b\/C4b binding sites","volume":"17","author":"Brouwers","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3233\/JAD-130533","article-title":"An updated meta-analysis of the association between SORL1 variants and the risk for sporadic Alzheimer\u2019s disease","volume":"37","author":"Jin","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"ref_49","first-page":"1565","article-title":"TREM2 and neurodegenerative disease","volume":"369","author":"Rajagopalan","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"13320","DOI":"10.1523\/JNEUROSCI.1224-13.2013","article-title":"CD33 Alzheimer\u2019s risk-altering polymorphism, CD33 expression, and exon 2 splicing","volume":"33","author":"Malik","year":"2013","journal-title":"J. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Miyashita, A., Koike, A., Jun, G., Wang, L.S., Takahashi, S., Matsubara, E., Kawarabayashi, T., Shoj, M., Tomita, N., and Arai, H. (2013). SORL1 is genetically associated with late-onset Alzheimer\u2019s disease in Japanese, Koreans and Caucasians. PLoS ONE, 8.","DOI":"10.1371\/annotation\/fcb56ea7-d32a-4e45-818d-39cef330c731"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","article-title":"Alzheimer\u2019s disease genetics: From the bench to the clinic","volume":"83","author":"Karch","year":"2014","journal-title":"Neuron"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.neurobiolaging.2013.08.011","article-title":"Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer\u2019s disease and frontotemporal dementia","volume":"35","author":"Ruiz","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1001\/jamaneurol.2014.1491","article-title":"Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: A genome-wide association study","volume":"71","author":"Naj","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12035-013-8536-1","article-title":"CD33 in Alzheimer\u2019s disease","volume":"49","author":"Jiang","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nature12825","article-title":"Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer\u2019s disease","volume":"505","author":"Cruchaga","year":"2014","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2217\/fnl.14.1","article-title":"Genetic loci associated with Alzheimer\u2019s disease","volume":"9","author":"Reitz","year":"2014","journal-title":"Future Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1093\/hmg\/ddu277","article-title":"Coding variants in TREM2 increase risk for Alzheimer\u2019s disease","volume":"23","author":"Jin","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_61","unstructured":"International Genomics of Alzheimer\u2019s Disease Consortium (IGAP) (2015). Convergent genetic and expression data implicate immunity in Alzheimer\u2019s disease. Alzheimers Dement., 11, 658\u2013671."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s12035-014-8723-8","article-title":"CR1 in Alzheimer\u2019s disease","volume":"51","author":"Zhu","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Lu, Y., Liu, W., and Wang, X. (2015). TREM2 variants and risk of Alzheimer\u2019s disease: A meta-analysis. Neurol. Sci.","DOI":"10.1007\/s10072-015-2274-2"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"21279","DOI":"10.1074\/jbc.M111.338376","article-title":"Role of phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) in intracellular amyloid precursor protein (APP) processing and amyloid plaque pathogenesis","volume":"287","author":"Xiao","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/sj.gene.6363964","article-title":"Interleukin-10 promoter polymorphism in sporadic Alzheimer\u2019s disease","volume":"4","author":"Lio","year":"2003","journal-title":"Genes Immun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.neurobiolaging.2004.08.010","article-title":"The association between promoter polymorphism of the interleukin-10 gene and Alzheimer\u2019s disease","volume":"26","author":"Ma","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.autrev.2011.09.005","article-title":"Alzheimer\u2019s disease, autoimmunity and inflammation. The good, the bad and the ugly","volume":"11","author":"Sardi","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000353395","article-title":"Effect of proinflammatory gene polymorphisms on the risk of Alzheimer\u2019s disease","volume":"13","author":"Flex","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ng.642","article-title":"Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson\u2019s disease","volume":"42","author":"Hamza","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/jnnp.2008.162883","article-title":"Association of the human leucocyte antigen region with susceptibility to Parkinson\u2019s disease","volume":"81","author":"Saiki","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Hill-Burns, E.M., Factor, S.A., Zabetian, C.P., Thomson, G., and Payami, H. (2011). Evidence for more than one Parkinson\u2019s disease-associated variant within the HLA region. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027109"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajhg.2013.10.009","article-title":"Association of Parkinson disease with structural and regulatory variants in the HLA region","volume":"93","author":"Wissemann","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s007020070078","article-title":"Genetic analysis of immunomodulating factors in sporadic Parkinson\u2019s disease","volume":"107","author":"Hardt","year":"2000","journal-title":"J. Neural Transm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3940(02)00300-2","article-title":"Association of interleukin-1 beta polymorphisms with idiopathic Parkinson\u2019s disease","volume":"326","author":"McGeer","year":"2002","journal-title":"Neurosci. Lett."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/jmg.39.6.400","article-title":"Association of an interleukin 1B gene polymorphism (-511) with Parkinson\u2019s disease in Finnish patients","volume":"39","author":"Mattila","year":"2002","journal-title":"J. Med. Genet."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ajmg.b.30136","article-title":"Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson\u2019s disease","volume":"133B","author":"Hakansson","year":"2005","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.64.6.836","article-title":"Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease","volume":"64","author":"Wahner","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.parkreldis.2008.02.001","article-title":"Interleukin-10 (IL10) and tumor necrosis factor alpha (TNF) gene polymorphisms in Parkinson\u2019s disease patients","volume":"14","author":"Bialecka","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2011.01.025","article-title":"Interleukin-18 promoter polymorphisms and risk of Parkinson\u2019s disease in a Han Chinese population","volume":"1381","author":"Xu","year":"2011","journal-title":"Brain Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/hmg\/dds492","article-title":"A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson\u2019s disease","volume":"22","author":"Holmans","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2013.02.024","article-title":"Polymorphisms in immune\/inflammatory cytokine genes are related to Parkinson\u2019s disease with cognitive impairment in the Han Chinese population","volume":"541","author":"Nie","year":"2013","journal-title":"Neurosci. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1468-1331.2008.02092.x","article-title":"Inflammation-related genes and the risk of Parkinson\u2019s disease: A multilocus approach","volume":"15","author":"Infante","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"122","DOI":"10.14802\/jmd.15033","article-title":"Genetics of progressive supranuclear palsy","volume":"8","author":"Im","year":"2015","journal-title":"J. Mov. Disord."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/jnnp.2005.063966","article-title":"The apolipoprotein E epsilon4 allele selectively increases the risk of frontotemporal lobar degeneration in males","volume":"77","author":"Srinivasan","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neurobiolaging.2005.03.008","article-title":"The effects of APOE and tau gene variability on risk of frontotemporal dementia","volume":"27","author":"Bernardi","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.ejhg.5200820","article-title":"Apolipoprotein E gene in frontotemporal dementia: An association study and meta-analysis","volume":"10","author":"Verpillat","year":"2002","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1212\/WNL.0b013e3181b6bb95","article-title":"Systemic inflammation and disease progression in Alzheimer disease","volume":"73","author":"Holmes","year":"2009","journal-title":"Neurology"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Miklossy, J. (2011). Emerging roles of pathogens in Alzheimer disease. Expert Rev. Mol. Med., 13.","DOI":"10.1017\/S1462399411002006"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1474-4422(14)70017-1","article-title":"Long-term cerebral consequences of sepsis","volume":"13","author":"Widman","year":"2014","journal-title":"Lancet Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jalz.2011.04.006","article-title":"Serum antibodies to periodontal pathogens are a risk factor for Alzheimer\u2019s disease","volume":"8","author":"Steffen","year":"2012","journal-title":"Alzheimers Dement."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neurobiolaging.2014.10.038","article-title":"Periodontal disease associates with higher brain amyloid load in normal elderly","volume":"36","author":"Kamer","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2008-13405","article-title":"Herpes simplex virus type 1 in Alzheimer\u2019s disease: The enemy within","volume":"13","author":"Itzhaki","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jalz.2008.12.001","article-title":"Alzheimer\u2019s disease and infection: Do infectious agents contribute to progression of Alzheimer\u2019s disease?","volume":"5","author":"Honjo","year":"2009","journal-title":"Alzheimers Dement."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Bu, X.L., Yao, X.Q., Jiao, S.S., Zeng, F., Liu, Y.H., Xiang, Y., Liang, C.R., Wang, Q.H., Wang, X., and Cao, H.Y. (2014). A study on the association between infectious burden and Alzheimer\u2019s disease. Eur. J. Neurol.","DOI":"10.1111\/ene.12477"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neurobiolaging.2013.06.024","article-title":"Herpes virus in Alzheimer\u2019s disease: Relation to progression of the disease","volume":"35","author":"Carbone","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jalz.2014.07.157","article-title":"Herpes simplex infection and the risk of Alzheimer\u2019s disease: A nested case-control study","volume":"11","author":"Gilthorpe","year":"2015","journal-title":"Alzheimers Dement."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/infdis\/jiu437","article-title":"Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals","volume":"211","author":"Barnes","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.bbadis.2008.08.001","article-title":"Viral parkinsonism","volume":"1792","author":"Jang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/00207454.2012.760560","article-title":"Infections as a risk factor for Parkinson\u2019s disease: A case-control study","volume":"123","author":"Vlajinac","year":"2013","journal-title":"Int. J. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","article-title":"Autoimmune disease and risk for Parkinson disease: A population-based case-control study","volume":"73","author":"Rugbjerg","year":"2009","journal-title":"Neurology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000333222","article-title":"Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: A nationwide epidemiological study from Sweden","volume":"10","author":"Li","year":"2012","journal-title":"Neurodgener. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(82)90820-0","article-title":"1918 influenza, encephalitis lethargica, parkinsonism","volume":"2","author":"Ravenholt","year":"1982","journal-title":"Lancet"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2010.03.057","article-title":"The probable relation between Toxoplasma gondii and Parkinson\u2019s disease","volume":"475","author":"Miman","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nn.4051","article-title":"Go with your gut: Microbiota meet microglia","volume":"18","author":"Mosher","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nn.4030","article-title":"Host microbiota constantly control maturation and function of microglia in the CNS","volume":"18","author":"Erny","year":"2015","journal-title":"Nat. Neurosci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature10434","article-title":"Peripheral education of the immune system by colonic commensal microbiota","volume":"478","author":"Stappenbeck","year":"2011","journal-title":"Nature"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mds.26069","article-title":"Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype","volume":"30","author":"Scheperjans","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","article-title":"Glial-neuronal interactions in Alzheimer\u2019s disease: The potential role of a \u201ccytokine cycle\u201d in disease progression","volume":"8","author":"Griffin","year":"1998","journal-title":"Brain Pathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0197-4580(01)00289-5","article-title":"Inflammation: Autotoxicity and Alzheimer disease","volume":"22","author":"McGeer","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0197-4580(01)00290-1","article-title":"Chemokines and Alzheimer\u2019s disease","volume":"22","author":"Streit","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"33","author":"Lee","year":"2010","journal-title":"Arch. Pharm. Res."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Rubio-Perez, J.M., and Morillas-Ruiz, J.M. (2012). A review: Inflammatory process in Alzheimer\u2019s disease, role of cytokines. Sci. World J.","DOI":"10.1100\/2012\/756357"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neurobiolaging.2009.02.025","article-title":"Microglia activation mediates fibrillar amyloid-beta toxicity in the aged primate cortex","volume":"32","author":"Leung","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2011-101815","article-title":"Expression profiles of cytokines in the brains of Alzheimer\u2019s disease (AD) patients, compared to the brains of non-demented patients with and without increasing AD pathology","volume":"25","author":"Morimoto","year":"2011","journal-title":"J. Alzheimer Dis."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-013-1177-7","article-title":"The amyloid cascade-inflammatory hypothesis of Alzheimer disease: Implications for therapy","volume":"126","author":"McGeer","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00401-013-1182-x","article-title":"Microglia actions in Alzheimer\u2019s disease","volume":"126","author":"Prokop","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_120","first-page":"358","article-title":"Immune attack: The role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nature"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000283480","article-title":"Neuroinflammation\u2014An early event in both the history and pathogenesis of Alzheimer\u2019s disease","volume":"7","author":"Eikelenboom","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"ref_123","first-page":"277","article-title":"Changes in cytokines and neurotrophins in Parkinson\u2019s disease","volume":"60","author":"Nagatsu","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1002\/ana.410440717","article-title":"Glial cells and inflammation in Parkinson\u2019s disease: A role in neurodegeneration?","volume":"44","author":"Hirsch","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref_125","first-page":"9","article-title":"Glial cell participation in the degeneration of dopaminergic neurons in Parkinson\u2019s disease","volume":"80","author":"Hirsch","year":"1999","journal-title":"Adv. Neurol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson\u2019s disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_127","first-page":"373","article-title":"Role of cytokines in inflammatory process in Parkinson\u2019s disease","volume":"70","author":"Sawada","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","article-title":"Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease","volume":"150","author":"Whitton","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2009.08.001","article-title":"The influence of microglia on the pathogenesis of Parkinson\u2019s disease","volume":"89","author":"Sullivan","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson\u2019s disease: Its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-398314-5.00004-0","article-title":"Inflammation in Parkinson\u2019s disease","volume":"88","author":"Tufekci","year":"2012","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of MHC class II-positive microglia and cytokine profile of Parkinson\u2019s disease v brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00401-004-0919-y","article-title":"Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains","volume":"109","author":"Imamura","year":"2005","journal-title":"Acta Neuropathol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson\u2019s disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C] (R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/S1353-8020(09)70814-4","article-title":"Neuroinflammation in the living brain of Parkinson\u2019s disease","volume":"15","author":"Ouchi","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.108.059998","article-title":"Imaging approaches to Parkinson disease","volume":"51","author":"Brooks","year":"2010","journal-title":"J. Nucl. Med."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients","volume":"202","author":"Muller","year":"1995","journal-title":"Neurosci. Lett."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/BF01291792","article-title":"Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain","volume":"103","author":"Mogi","year":"1996","journal-title":"J. Neural Transm."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"7531","DOI":"10.1073\/pnas.94.14.7531","article-title":"Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease","volume":"94","author":"Hunot","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: Role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10048-006-0077-6","article-title":"The medial and lateral substantia nigra in Parkinson\u2019s disease: mRNA profiles associated with higher brain tissue vulnerability","volume":"8","author":"Duke","year":"2007","journal-title":"Neurogenetics"},{"key":"ref_145","first-page":"113","article-title":"Biochemistry of post-mortem brains in Parkinson\u2019s disease: Historical overview and future prospects","volume":"72","author":"Nagatsu","year":"2007","journal-title":"J. Neural Transm. Suppl."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","article-title":"Neurodegeneration and inflammation in Parkinson\u2019s disease","volume":"18","author":"Phani","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_148","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF00294180","article-title":"Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Straussler syndrome","volume":"87","author":"Guiroy","year":"1994","journal-title":"Acta Neuropathol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1750-3639.1998.tb00167.x","article-title":"Role of microglia in neuronal cell death in prion disease","volume":"8","author":"Giese","year":"1998","journal-title":"Brain Pathol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.1227901","article-title":"Microglia: Scapegoat, saboteur, or something else?","volume":"339","author":"Aguzzi","year":"2013","journal-title":"Science"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/nri3553","article-title":"The immunobiology of prion diseases","volume":"13","author":"Aguzzi","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_153","first-page":"51","article-title":"Microglial and astrocytic change in brains of Creutzfeldt-Jakob disease: An immunocytochemical and quantitative study","volume":"18","author":"Aoki","year":"1999","journal-title":"Clin. Neuropathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2990.1995.tb01097.x","article-title":"Reactive microglia in Creutzfeldt-Jakob disease","volume":"21","author":"Muhleisen","year":"1995","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/380345a0","article-title":"Role of microglia and host prion protein in neurotoxicity of a prion protein fragment","volume":"380","author":"Brown","year":"1996","journal-title":"Nature"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005072-199803000-00006","article-title":"Microglia and the development of spongiform change in Creutzfeldt-Jakob disease","volume":"57","author":"Eitzen","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1128\/JVI.73.6.5089-5097.1999","article-title":"Microglial activation varies in different models of Creutzfeldt-Jakob disease","volume":"73","author":"Baker","year":"1999","journal-title":"J. Virol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-0173(01)00042-X","article-title":"Microglia and the pathogenesis of spongiform encephalopathies","volume":"35","author":"Rezaie","year":"2001","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0197-4580(01)00236-6","article-title":"The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease","volume":"23","author":"Dewulf","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1073\/pnas.0237313100","article-title":"Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease","volume":"100","author":"Baker","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/01.jnen.0000183346.19447.55","article-title":"Sporadic Creutzfeldt-Jakob disease: The extent of microglia activation is dependent on the biochemical type of PrPSc","volume":"64","author":"Puoti","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_162","first-page":"202","article-title":"The brain immune response in human prion diseases. Microglial activation and microglial disease. I. Sporadic Creutzfeldt-Jakob disease","volume":"44","author":"Szpak","year":"2006","journal-title":"Folia Neuropathol."},{"key":"ref_163","first-page":"74","article-title":"Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer\u2019s disease: Morphometric study and review of the literature","volume":"50","author":"Wojtera","year":"2012","journal-title":"Folia Neuropathol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1743-422X-10-216","article-title":"Brain microglia were activated in sporadic CJD but almost unchanged in fatal familial insomnia and G114V genetic CJD","volume":"10","author":"Shi","year":"2013","journal-title":"Virol. J."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1212\/WNL.52.6.1289","article-title":"Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease","volume":"52","author":"Sharief","year":"1999","journal-title":"Neurology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1128\/JVI.76.21.10905-10913.2002","article-title":"Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles","volume":"76","author":"Baker","year":"2002","journal-title":"J. Virol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1080\/15287394.2011.618973","article-title":"Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome","volume":"74","author":"Lukiw","year":"2011","journal-title":"J. Toxicol. Environ. Health A"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jneuroim.2005.10.008","article-title":"Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease","volume":"172","author":"Stoeck","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-014-0170-y","article-title":"Immune responses in rapidly progressive dementia: A comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer\u2019s disease and multiple sclerosis","volume":"11","author":"Stoec","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0304-3940(93)90147-D","article-title":"Microglial reaction in Pick\u2019s disease","volume":"161","author":"Paulus","year":"1993","journal-title":"Neurosci. Lett."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/brain\/awg085","article-title":"Severity of gliosis in Pick\u2019s disease and frontotemporal lobar degeneration: Tau-positive glia differentiate these disorders","volume":"126","author":"Schofield","year":"2003","journal-title":"Brain"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.parkreldis.2011.06.007","article-title":"Cytokine expression and microglial activation in progressive supranuclear palsy","volume":"17","author":"Ahmed","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/nan.12092","article-title":"Patterns of microglial cell activation in frontotemporal lobar degeneration","volume":"40","author":"Lant","year":"2014","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000322228","article-title":"Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation","volume":"8","author":"Bellucci","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bpa.12137","article-title":"Complex deregulation and expression of cytokines and mediators of the immune response in Parkinson\u2019s disease brain is region dependent","volume":"24","author":"Llorens","year":"2014","journal-title":"Brain Pathol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fnagi.2014.00198","article-title":"Subtype and regional-specific neuroinflammation in sporadic Creutzfeldt-Jakob disease","volume":"6","author":"Llorens","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/NEN.0000000000000176","article-title":"Neuroinflammatory signals in Alzheimer disease and APP\/PS1 transgenic mice: Correlations with plaques, tangles, and oligomeric species","volume":"74","author":"Aso","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/glia.10319","article-title":"Dystrophic microglia in the aging human brain","volume":"45","author":"Streit","year":"2004","journal-title":"Glia"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00401-009-0556-6","article-title":"Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer\u2019s disease","volume":"118","author":"Streit","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1016\/j.neurobiolaging.2008.01.014","article-title":"Inflammatory markers in AD and MCI patients with different biomarker profiles","volume":"30","author":"Schuitemaker","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000245156","article-title":"Peripheral cytokines and chemokines in Alzheimer\u2019s disease","volume":"28","author":"Lee","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000255051","article-title":"Increased serum IL-1beta level in Alzheimer\u2019s disease and mild cognitive impairment","volume":"28","author":"Forlenza","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exger.2009.08.003","article-title":"Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease","volume":"45","author":"Fiala","year":"2010","journal-title":"Exp. Gerontol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2011.12.015","article-title":"Elevation of serum TNF-\u03b1 levels in mild and moderate Alzheimer patients with daytime sleepiness","volume":"244","author":"Chen","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.neurobiolaging.2012.09.012","article-title":"Neuroinflammatory phenotype in early Alzheimer\u2019s disease","volume":"34","author":"Sudduth","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2015.04.014","article-title":"The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer\u2019s disease, mild cognitive impairment or Parkinson\u2019s disease","volume":"283","author":"Dursun","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3233\/JAD-2010-100921","article-title":"Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer\u2019s disease","volume":"22","author":"Diniz","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.0b013e318225ae07","article-title":"Pro-inflammatory cytokines, sickness behavior, and Alzheimer disease","volume":"77","author":"Holmes","year":"2011","journal-title":"Neurology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JPD-130250","article-title":"The role of innate and adaptive immunity in Parkinson\u2019s disease","volume":"3","author":"Kannarkat","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bbi.2008.07.003","article-title":"Peripheral cytokines profile in Parkinson\u2019s disease","volume":"23","author":"Reale","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jneuroim.2012.07.015","article-title":"Reduced T helper and B lymphocytes in Parkinson\u2019s disease","volume":"252","author":"Stevens","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0753-3322(99)80079-1","article-title":"IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson\u2019s disease","volume":"53","author":"Bessler","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.parkreldis.2008.05.014","article-title":"Serum inflammatory biomarkers in Parkinson\u2019s disease","volume":"15","author":"Dufek","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1600-0404.2007.00894.x","article-title":"Circulating interleukin-15 and RANTES chemokine in Parkinson\u2019s disease","volume":"116","author":"Rentzos","year":"2007","journal-title":"Acta Neurol. Scand."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0404.2008.01103.x","article-title":"Circulating interleukin-10 and interleukin-12 in Parkinson\u2019s disease","volume":"119","author":"Rentzos","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jneuroim.2009.08.001","article-title":"Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson\u2019s disease","volume":"216","author":"Scalzo","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cyto.2012.07.030","article-title":"Inflammatory cytokines and NT-proCNP in Parkinson\u2019s disease patients","volume":"60","author":"Koziorowski","year":"2012","journal-title":"Cytokine"},{"key":"ref_201","first-page":"474","article-title":"The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson\u2019s disease","volume":"51","author":"Menza","year":"2010","journal-title":"Psychosomatics"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-5956-10-71","article-title":"An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes","volume":"10","author":"Mahlknecht","year":"2012","journal-title":"Proteome Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/2\/206\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:18:46Z","timestamp":1760210326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/2\/206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,4]]},"references-count":202,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2]]}},"alternative-id":["ijms17020206"],"URL":"https:\/\/doi.org\/10.3390\/ijms17020206","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,4]]}}}